| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Vorinostat | gCSI | pan-cancer | AAC | -0.22 | 9e-05 |
| mRNA | PD-0325901 | gCSI | pan-cancer | AAC | 0.18 | 0.002 |
| mRNA | bid1870 | gCSI | pan-cancer | AAC | 0.17 | 0.005 |
| mRNA | Crizotinib | gCSI | pan-cancer | AAC | 0.16 | 0.01 |
| mRNA | Rapamycin | gCSI | pan-cancer | AAC | -0.15 | 0.01 |
| mRNA | MS-275 | gCSI | pan-cancer | AAC | 0.13 | 0.02 |
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | 0.15 | 0.02 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | 0.11 | 0.07 |
| mRNA | lapatinib | gCSI | pan-cancer | AAC | 0.061 | 0.3 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | -0.06 | 0.3 |